Novel nutraceutical supplements modulate biomarkers associated with non-alcoholic fatty liver disease (NAFLD)
LIVER
In our cohort, liver and renal functions were estimated by liver enzymes and creatinine, respectively. The liver enzymes AST (Liver enzymes, AST/ALT ratio (AAR), and creatinine at baseline time (Day 0) and 90 and 180 days post-supplementation. 